EUVIMEDEUVIMED entdecken
Crossref

Real-World Pharmacokinetics-Pharmacodynamics and Pharmacogenomic Analysis of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients with Active Ulcerative Colitis

Masahide FUKUDO

Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics · 2026 · 57 (3) · 30-34

DOI: 10.3999/jscpt.57.3_30 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 2026. Verfasst von Masahide FUKUDO. Die Arbeit nennt 13 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

FUKUDO, M. (2026). Real-World Pharmacokinetics-Pharmacodynamics and Pharmacogenomic Analysis of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients with Active Ulcerative Colitis. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 57(3), 30-34. https://doi.org/10.3999/jscpt.57.3_30

Vancouver

FUKUDO M. Real-World Pharmacokinetics-Pharmacodynamics and Pharmacogenomic Analysis of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients with Active Ulcerative Colitis. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 2026;57(3):30-34. doi:10.3999/jscpt.57.3_30

BibTeX
@article{FUKUDO2026,
  author = {FUKUDO, Masahide},
  title = {Real-World Pharmacokinetics-Pharmacodynamics and Pharmacogenomic Analysis of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients with Active Ulcerative Colitis},
  journal = {Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics},
  year = {2026},
  volume = {57},
  number = {3},
  pages = {30--34},
  doi = {10.3999/jscpt.57.3_30}
}
Kostenlos starten →